SandboxAlonso: Difference between revisions
Jump to navigation
Jump to search
Line 61: | Line 61: | ||
{{familytree/start}} | {{familytree/start}} | ||
{{familytree | | | | | A01 | | | | | A01=Controls of history + physical exam and chest CT with or without contrast every 6-12 months (first 2 years), then annual controls}} | {{familytree | | | | | A01 | | | | | A01=Controls of history + physical exam and chest [[CT]] with or without contrast every 6-12 months (first 2 years), then annual controls}} | ||
{{familytree | | | | | |!| | | | | | |}} | {{familytree | | | | | |!| | | | | | |}} | ||
{{familytree | | | | | B01 | | | | | B01=Is there evidence of local or regional recurrence<br>OR<br>systemic metastasis?}} | {{familytree | | | | | B01 | | | | | B01=Is there evidence of local or regional recurrence<br>OR<br>systemic [[metastasis]]?}} | ||
{{familytree | | | |,|-|^|-|.| | | |}} | {{familytree | | | |,|-|^|-|.| | | |}} | ||
{{familytree | | | C01 | | C02 | | | C01=Local or regional recurrence|C02=Systemic metastasis}} | {{familytree | | | C01 | | C02 | | | C01=Local or regional recurrence|C02=Systemic [[metastasis]]}} | ||
{{familytree/end}} | {{familytree/end}} | ||
Revision as of 19:31, 20 June 2014
Stage IV
Is pleural or pericardial effusion present (suggestive of M1a) or are findings suggestive of systemic metastasis (M1b) present? | |||||||||||||||||||||||||||||||||||||||||||||
M1a | M1b | ||||||||||||||||||||||||||||||||||||||||||||
Perform the following tests:
| Perform the following tests:
| ||||||||||||||||||||||||||||||||||||||||||||
Is the liquid extracted positive for malignant cells? | Are findings suggestive of adrenal metastasis or brain metastasis? | ||||||||||||||||||||||||||||||||||||||||||||
Yes | No | Adrenal | Brain | ||||||||||||||||||||||||||||||||||||||||||
Local therapy
PLUS | Perform a needle aspiration biopsy for metastasis confirmation | Surgical resection + adjuvant radiation therapy Radiation therapy alone:
PLUS | |||||||||||||||||||||||||||||||||||||||||||
What is the TN stage of the lung tumor? | |||||||||||||||||||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||||||||||||||||
| Administer therapy for metastatic disease in case of not curable lung lesions (click here for the treatment of local and systemic metastasis and neoplastic recurrence) | ||||||||||||||||||||||||||||||||||||||||||||
Follow-up
Controls of history + physical exam and chest CT with or without contrast every 6-12 months (first 2 years), then annual controls | |||||||||||||||||||||||||
Is there evidence of local or regional recurrence OR systemic metastasis? | |||||||||||||||||||||||||
Local or regional recurrence | Systemic metastasis | ||||||||||||||||||||||||
Local or regional recurrence
What is the site of the recurrence? | |||||||||||||||||||||||||||||||||||||||||||
Bronchial obstruction | Mediastinal lymph node | Superior vena cava obstruction | Severe hemoptisis | Resectable tumor | |||||||||||||||||||||||||||||||||||||||
Surgical correction of the obstruction: laser therapy, stent or any other surgical procedure OR Radiation therapy (external-beam or brachytherapy) OR Photodynamic therapy | Has the patient received radiation therapy? | Chemotherapy + radiation therapy OR External-beam radiation therapy OR Superior vena cava stent collocation | Surgery OR Radiation therapy (external-beam or brachytherapy) OR Laser therapy, photodynamic therapy or tumor embolization | Tumor resection (preferred option) OR Radiation therapy (stereotactic ablative radiotherapy or external-beam radiation therapy) | |||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||
Administer systemic therapy | Administer chemotherapy + radiation therapy | ||||||||||||||||||||||||||||||||||||||||||
Are findings suggestive of disseminated disease present? | |||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||
Click here for the treatment of metastatic disease | Observation OR systemic therapy | ||||||||||||||||||||||||||||||||||||||||||
Systemic metastasis
What are the characteristics of the metastasis? | |||||||||||||||||||||||||||||||||||||||||||
Diffuse brain metastasis | Bone metastasis | Localized symptoms | Solitary metastasis | Multiple metastasis | |||||||||||||||||||||||||||||||||||||||
External-beam radiation therapy (palliative) | External-beam radiation therapy (palliative) + limb stabilization (prevention of pathological fractures) Denosumab or biophosphonate therapy should be considered | External-beam radiation therapy (palliative) | Click here for the treatment of stage IV M1b (solitary site metastasis) | Click here for the treatment of metastatic disease | |||||||||||||||||||||||||||||||||||||||
Click here for the treatment of metastatic disease | |||||||||||||||||||||||||||||||||||||||||||
Metastatic disease
What the specific subtype according to the specific histological characteristics of the tumor? | |||||||||||||||||||||||||||||||||||||||
| Squamous cell carcinoma | ||||||||||||||||||||||||||||||||||||||
Perform specific EGFR and ALK mutation testing: What is the specific mutation? | Is the patient a smoker or former smoker? | ||||||||||||||||||||||||||||||||||||||
Sensitizing EGFR mutation | ALK mutation | Negative EGFR and ALK | Click here for the squamous cell carcinoma specific treatment | ||||||||||||||||||||||||||||||||||||
Click here for the sensitizing EGFR mutation specific treatment | Click here for the specific therapy for the ALK mutation specific treatment | Click here for the treatment of negative sensitizing EGFR and ALK mutation metastatic disease | |||||||||||||||||||||||||||||||||||||